Yehuda Carmeli
#119,569
Most Influential Person Now
Yehuda Carmeli's AcademicInfluence.com Rankings
Yehuda Carmelibiology Degrees
Biology
#7162
World Rank
#10036
Historical Rank
Microbiology
#350
World Rank
#398
Historical Rank
Neuroscience
#900
World Rank
#936
Historical Rank
Download Badge
Biology
Yehuda Carmeli's Degrees
- PhD Microbiology Tel Aviv University
- Masters Microbiology Tel Aviv University
- Bachelors Biology Tel Aviv University
Similar Degrees You Can Earn
Why Is Yehuda Carmeli Influential?
(Suggest an Edit or Addition)Yehuda Carmeli's Published Works
Number of citations in a given year to any of this author's works
Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author
Published Works
- Multidrug-resistant, extensively drug-resistant and pandrug-resistant bacteria: an international expert proposal for interim standard definitions for acquired resistance. (2012) (8638)
- Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. (2017) (2610)
- Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. (2003) (2063)
- Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. (2003) (1003)
- The Impact of Methicillin Resistance in Staphylococcus aureus Bacteremia on Patient Outcomes: Mortality, Length of Stay, and Hospital Charges (2005) (962)
- Rapid evolution and spread of carbapenemases among Enterobacteriaceae in Europe. (2012) (796)
- Emergence of Antibiotic-Resistant Pseudomonas aeruginosa: Comparison of Risks Associated with Different Antipseudomonal Agents (1999) (606)
- Mortality and delay in effective therapy associated with extended-spectrum beta-lactamase production in Enterobacteriaceae bacteraemia: a systematic review and meta-analysis. (2007) (605)
- Multidrug-Resistant Pseudomonas aeruginosa: Risk Factors and Clinical Impact (2006) (600)
- The impact of antimicrobial resistance on health and economic outcomes. (2003) (582)
- Clinical and Economic Impact of Common Multidrug-Resistant Gram-Negative Bacilli (2007) (573)
- Prolonged antibiotic prophylaxis after cardiovascular surgery and its effect on surgical site infections and antimicrobial resistance. (2000) (554)
- The negative impact of antibiotic resistance. (2016) (496)
- A multinational survey of risk factors for infection with extended-spectrum beta-lactamase-producing enterobacteriaceae in nonhospitalized patients. (2009) (493)
- Molecular Epidemiology of KPC-Producing Klebsiella pneumoniae Isolates in the United States: Clonal Expansion of Multilocus Sequence Type 258 (2009) (490)
- Predictors of Carbapenem-Resistant Klebsiella pneumoniae Acquisition among Hospitalized Adults and Effect of Acquisition on Mortality (2007) (485)
- Containment of a country-wide outbreak of carbapenem-resistant Klebsiella pneumoniae in Israeli hospitals via a nationally implemented intervention. (2011) (413)
- Occurrence of carbapenemase-producing Klebsiella pneumoniae and Escherichia coli in the European survey of carbapenemase-producing Enterobacteriaceae (EuSCAPE): a prospective, multinational study. (2017) (407)
- Clinical and Economic Impact of Bacteremia with Extended- Spectrum-β-Lactamase-Producing Enterobacteriaceae (2006) (398)
- Health and economic outcomes of antibiotic resistance in Pseudomonas aeruginosa. (1999) (374)
- Fluoroquinolones and the Risk for Methicillin-resistant Staphylococcus aureus in Hospitalized Patients (2003) (368)
- Epidemic of carbapenem-resistant Klebsiella pneumoniae in Europe is driven by nosocomial spread (2019) (359)
- Effect of appropriate combination therapy on mortality of patients with bloodstream infections due to carbapenemase-producing Enterobacteriaceae (INCREMENT): a retrospective cohort study. (2017) (347)
- Influx of extended-spectrum beta-lactamase-producing enterobacteriaceae into the hospital. (2006) (340)
- Worldwide Diversity of Klebsiella pneumoniae That Produce β-Lactamase blaKPC-2 Gene (2010) (331)
- Colistin alone versus colistin plus meropenem for treatment of severe infections caused by carbapenem-resistant Gram-negative bacteria: an open-label, randomised controlled trial. (2018) (328)
- Association between carriage of Streptococcus pneumoniae and Staphylococcus aureus in Children. (2004) (313)
- Effect of an investigational vaccine for preventing Staphylococcus aureus infections after cardiothoracic surgery: a randomized trial. (2013) (308)
- Health and economic outcomes of the emergence of third-generation cephalosporin resistance in Enterobacter species. (2002) (306)
- Carbapenem-non-susceptible Enterobacteriaceae in Europe: conclusions from a meeting of national experts. (2010) (294)
- Emergence of KPC-2 and KPC-3 in Carbapenem-Resistant Klebsiella pneumoniae Strains in an Israeli Hospital (2007) (282)
- Carbapenem-resistant Enterobacteriaceae: a potential threat. (2008) (277)
- Ceftazidime-avibactam or best available therapy in patients with ceftazidime-resistant Enterobacteriaceae and Pseudomonas aeruginosa complicated urinary tract infections or complicated intra-abdominal infections (REPRISE): a randomised, pathogen-directed, phase 3 study. (2016) (275)
- Update on Pseudomonas aeruginosa and Acinetobacter baumannii infections in the healthcare setting (2005) (271)
- Methodological principles of case-control studies that analyzed risk factors for antibiotic resistance: a systematic review. (2001) (267)
- Controlling the spread of carbapenemase-producing Gram-negatives: therapeutic approach and infection control. (2010) (267)
- High tigecycline resistance in multidrug-resistant Acinetobacter baumannii. (2007) (259)
- Carbapenemase-producing Enterobacteriaceae in Europe: a survey among national experts from 39 countries, February 2013. (2013) (257)
- Health and economic outcomes of vancomycin-resistant enterococci. (2002) (256)
- Improved antimicrobial peptides based on acyl-lysine oligomers (2007) (232)
- Combination therapy for carbapenem-resistant Gram-negative bacteria. (2014) (225)
- Factors associated with candidemia caused by non-albicans Candida species versus Candida albicans in the intensive care unit. (2008) (223)
- Multidrug-Resistant Acinetobacter baumannii (2005) (206)
- Isolation of Imipenem-Resistant Enterobacter Species: Emergence of KPC-2 Carbapenemase, Molecular Characterization, Epidemiology, and Outcomes (2008) (201)
- Imipenem-resistant Pseudomonas aeruginosa: risk factors and antibiotic susceptibility patterns. (1997) (201)
- Epidemiology and clinical outcomes of patients with multiresistant Pseudomonas aeruginosa. (1999) (200)
- Interventional strategies and current clinical experience with carbapenemase-producing Gram-negative bacteria. (2012) (199)
- Systematic Review and Meta-Analysis of In Vitro Synergy of Polymyxins and Carbapenems (2013) (199)
- An ongoing national intervention to contain the spread of carbapenem-resistant enterobacteriaceae. (2014) (185)
- Parallel analysis of individual and aggregated data on antibiotic exposure and resistance in gram-negative bacilli. (2001) (183)
- Mupirocin prophylaxis to prevent Staphylococcus aureus infection in patients undergoing dialysis: a meta-analysis. (2003) (182)
- First Report on a Hyperepidemic Clone of KPC-3-Producing Klebsiella pneumoniae in Israel Genetically Related to a Strain Causing Outbreaks in the United States (2008) (182)
- Carbapenem‐resistant Enterobacteriaceae: biology, epidemiology, and management (2014) (179)
- Plasmid-Mediated Imipenem-Hydrolyzing Enzyme KPC-2 among Multiple Carbapenem-Resistant Escherichia coli Clones in Israel (2006) (177)
- Effects of Antibiotics on Nosocomial Epidemiology of Vancomycin-Resistant Enterococci (2002) (174)
- Control-group selection importance in studies of antimicrobial resistance: examples applied to Pseudomonas aeruginosa, Enterococci, and Escherichia coli. (2002) (173)
- Risk Factors for Emergence of Resistance to Broad-Spectrum Cephalosporins among Enterobacterspp (2001) (171)
- High Levels of Antimicrobial Coresistance among Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae (2005) (170)
- Antecedent Treatment with Different Antibiotic Agents as a Risk Factor for Vancomycin-Resistant Enterococcus (2002) (169)
- Ceftazidime-Avibactam as Salvage Therapy for Infections Caused by Carbapenem-Resistant Organisms (2016) (162)
- Prior Antimicrobial Therapy and Risk for Hospital-Acquired Candida glabrata and Candida krusei Fungemia: a Case-Case-Control Study (2005) (160)
- Surveillance Cultures and Duration of Carriage of Multidrug-Resistant Acinetobacter baumannii (2007) (154)
- The Case-Case-Control Study Design: Addressing the Limitations of Risk Factor Studies for Antimicrobial Resistance (2005) (152)
- Consensus review of the epidemiology and appropriate antimicrobial therapy of complicated urinary tract infections in Asia-Pacific region. (2011) (148)
- Evaluation of PCR-Based Testing for Surveillance of KPC-Producing Carbapenem-Resistant Members of the Enterobacteriaceae Family (2009) (147)
- Epidemiological Interpretation of Studies Examining the Effect of Antibiotic Usage on Resistance (2013) (147)
- Asymptomatic rectal carriage of blaKPC producing carbapenem-resistant Enterobacteriaceae: who is prone to become clinically infected? (2013) (146)
- The association between antecedent vancomycin treatment and hospital-acquired vancomycin-resistant enterococci: a meta-analysis. (1999) (146)
- Glycopeptides are no more effective than beta-lactam agents for prevention of surgical site infection after cardiac surgery: a meta-analysis. (2004) (144)
- Risk factors for albicans and non-albicans candidemia in the intensive care unit* (2008) (143)
- Raising Standards While Watching the Bottom Line Making a Business Case for Infection Control (2007) (141)
- Transfer of Carbapenem-Resistant Plasmid from Klebsiella pneumoniae ST258 to Escherichia coli in Patient (2010) (141)
- Methicillin-resistant Staphylococcus aureus in Neonatal Intensive Care Unit (2005) (141)
- Carriage of Methicillin-Resistant Staphylococcus Aureus at Hospital Admission (1998) (140)
- Antibacterial Properties of Dermaseptin S4 Derivatives with In Vivo Activity (2002) (135)
- National Multicenter Study of Predictors and Outcomes of Bacteremia upon Hospital Admission Caused by Enterobacteriaceae Producing Extended-Spectrum β-Lactamases (2010) (133)
- SME-Type Carbapenem-Hydrolyzing Class A β-Lactamases from Geographically Diverse Serratia marcescens Strains (2000) (128)
- A survey on handwashing practices and opinions of healthcare workers. (2000) (127)
- A Multinational, Preregistered Cohort Study of β-Lactam/β-Lactamase Inhibitor Combinations for Treatment of Bloodstream Infections Due to Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae (2016) (127)
- Laboratory and Clinical Evaluation of Screening Agar Plates for Detection of Carbapenem-Resistant Enterobacteriaceae from Surveillance Rectal Swabs (2011) (123)
- Impact of quinolone restriction on resistance patterns of Escherichia coli isolated from urine by culture in a community setting. (2009) (123)
- Gastrointestinal colonization by KPC-producing Klebsiella pneumoniae following hospital discharge: duration of carriage and risk factors for persistent carriage. (2013) (117)
- Impact of multi-drug-resistant Acinetobacter baumannii on clinical outcomes (2007) (115)
- [Genetics of inflammatory bowel diseases]. (1993) (112)
- MLST reveals potentially high-risk international clones of Enterobacter cloacae. (2015) (107)
- Complete Nucleotide Sequence of KPC-3-Encoding Plasmid pKpQIL in the Epidemic Klebsiella pneumoniae Sequence Type 258 (2010) (106)
- A 5-day course of oral antibiotics followed by faecal transplantation to eradicate carriage of multidrug-resistant Enterobacteriaceae: a randomized clinical trial. (2019) (98)
- Infection control and prevention measures to reduce the spread of vancomycin-resistant enterococci in hospitalized patients: a systematic review and meta-analysis. (2014) (96)
- Epidemiological interpretation of antibiotic resistance studies – what are we missing? (2004) (95)
- Carbapenem-Resistant Klebsiella pneumoniae in Post-Acute-Care Facilities in Israel (2011) (94)
- Risk factors for nosocomial candiduria due to Candida glabrata and Candida albicans. (1999) (94)
- Reference Group Choice and Antibiotic Resistance Outcomes (2004) (93)
- Dissemination of an NDM-2-Producing Acinetobacter baumannii Clone in an Israeli Rehabilitation Center (2011) (92)
- Molecular Epidemiology, Sequence Types, and Plasmid Analyses of KPC-Producing Klebsiella pneumoniae Strains in Israel (2010) (89)
- Plasmid pKpQIL encoding KPC-3 and TEM-1 confers carbapenem resistance in an extremely drug-resistant epidemic Klebsiella pneumoniae strain. (2010) (88)
- Reduced susceptibility to chlorhexidine among extremely-drug-resistant strains of Klebsiella pneumoniae. (2012) (86)
- A Predictive Model of Mortality in Patients With Bloodstream Infections due to Carbapenemase-Producing Enterobacteriaceae. (2016) (85)
- A Call for Action: The Application of the International Health Regulations to the Global Threat of Antimicrobial Resistance (2011) (84)
- Extended-Spectrum Beta-Lactamases among Enterobacter Isolates Obtained in Tel Aviv, Israel (2005) (83)
- Extended-Spectrum β-Lactamase Production Is Associated with an Increase in Cell Invasion and Expression of Fimbrial Adhesins in Klebsiella pneumoniae (2008) (82)
- Predictors of Mortality in Patients with Bloodstream Infection Due to Ceftazidime-Resistant Klebsiella pneumoniae (2006) (80)
- Hospital-acquired infective endocarditis: should the definition be broadened? (2004) (80)
- Environmental Contamination by Carbapenem-Resistant Enterobacteriaceae (2012) (79)
- Intercontinental spread from Israel to Colombia of a KPC-3-producing Klebsiella pneumoniae strain. (2011) (79)
- Benign familial leukopenia and neutropenia in different ethnic groups (1988) (77)
- How to stem the tide of carbapenemase-producing Enterobacteriaceae?: proactive versus reactive strategies (2010) (77)
- CTX-M-2 and a New CTX-M-39 Enzyme Are the Major Extended-Spectrum Beta-Lactamases in Multiple Escherichia coli Clones Isolated in Tel Aviv, Israel (2005) (77)
- Treatment with Fluoroquinolones or with β-Lactam-β-Lactamase Inhibitor Combinations Is a Risk Factor for Isolation of Extended-Spectrum-β-Lactamase-Producing Klebsiella Species in Hospitalized Patients (2010) (77)
- Spread of KPC-producing carbapenem-resistant Enterobacteriaceae: the importance of super-spreaders and rectal KPC concentration. (2015) (73)
- Estimating the number of infections caused by antibiotic-resistant Escherichia coli and Klebsiella pneumoniae in 2014: a modelling study. (2018) (73)
- Carbapenem-Resistant Enterobacteriaceae: A Strategic Roadmap for Infection Control (2017) (72)
- Treatment outcomes of colistin and carbapenem-resistant Acinetobacter baumannii infections: an exploratory subgroup analysis of a randomized clinical trial. (2018) (72)
- Predictors of Rectal Carriage of Carbapenem-Resistant Enterobacteriaceae (CRE) among Patients with Known CRE Carriage at Their Next Hospital Encounter (2011) (71)
- A national survey of the molecular epidemiology of Clostridium difficile in Israel: the dissemination of the ribotype 027 strain with reduced susceptibility to vancomycin and metronidazole. (2015) (69)
- Biofilm formation and susceptibility to gentamicin and colistin of extremely drug-resistant KPC-producing Klebsiella pneumoniae. (2014) (68)
- Risk Factors for Recovery of Ampicillin-Sulbactam-Resistant Escherichia coli in Hospitalized Patients (2000) (67)
- Acinetobacter baumannii: emergence and spread in Israeli hospitals 1997–2002 (2005) (67)
- Transmission dynamics of ESBL-producing Escherichia coli clones in rehabilitation wards at a tertiary care centre. (2012) (65)
- Analogous oligo‐acyl‐lysines with distinct antibacterial mechanisms (2008) (63)
- Carbapenem stewardship: does ertapenem affect Pseudomonas susceptibility to other carbapenems? A review of the evidence. (2012) (63)
- Introduction of OXA-48-producing Enterobacteriaceae to Israeli hospitals by medical tourism. (2011) (63)
- Pseudomonas aeruginosa and the Oropharyngeal Ecosystem of Tube-Fed Patients (2003) (61)
- Ertapenem Resistance among Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Isolates (2009) (60)
- Gram-negative bacteremia upon hospital admission: when should Pseudomonas aeruginosa be suspected? (2009) (59)
- Bloodstream infections among carriers of carbapenem-resistant Klebsiella pneumoniae: etiology, incidence and predictors. (2015) (58)
- Endocarditis Caused by Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae: Emergence of Resistance to Ciprofloxacin and Piperacillin-Tazobactam during Treatment despite Initial Susceptibility (2006) (58)
- Occurrence and Phenotypic Characteristics of Extended-Spectrum β-Lactamases among Members of the Family Enterobacteriaceae at the Tel-Aviv Medical Center (Israel) and Evaluation of Diagnostic Tests (2003) (58)
- Clonal Structure, Extended-Spectrum β-Lactamases, and Acquired AmpC-Type Cephalosporinases of Escherichia coli Populations Colonizing Patients in Rehabilitation Centers in Four Countries (2012) (58)
- Incidence of Carbapenem-Resistant Gram Negatives in Italian Transplant Recipients: A Nationwide Surveillance Study (2015) (58)
- Persistence of Klebsiella pneumoniae ST258 as the predominant clone of carbapenemase-producing Enterobacteriaceae in post-acute-care hospitals in Israel, 2008-13. (2015) (57)
- Mechanisms by which antibiotics promote dissemination of resistant pneumococci in human populations. (2006) (57)
- Molecular and Epidemiologic Study of Polyclonal Outbreaks of Multidrug-Resistant Acinetobacter baumannii Infection in an Israeli Hospital (2007) (56)
- Erroneous Reporting of Coagulase-Negative Staphylococci as Kocuria spp. by the Vitek 2 System (2005) (56)
- A case-control study to identify predictors of 14-day mortality following carbapenem-resistant Acinetobacter baumannii bacteraemia. (2014) (55)
- Differential Effects of Levofloxacin and Ciprofloxacin on the Risk for Isolation of Quinolone-Resistant Pseudomonas aeruginosa (2006) (54)
- Treatment with a Broad-Spectrum Cephalosporin versus Piperacillin-Tazobactam and the Risk for Isolation of Broad-Spectrum Cephalosporin-Resistant Enterobacter Species (2003) (54)
- Treatment Options for Multidrug-Resistant Acinetobacter Species (2012) (52)
- Impact of Severity of Illness Bias and Control Group Misclassification Bias in Case-Control Studies of Antimicrobial-Resistant Organisms (2005) (52)
- Systematic review of antibiotic consumption in acute care hospitals. (2016) (52)
- Case-control study to identify factors associated with mortality among patients with methicillin-resistant Staphylococcus aureus bacteraemia. (2010) (51)
- Plasmid-Mediated qnrB2 and Carbapenemase Gene blaKPC-2 Carried on the Same Plasmid in Carbapenem-Resistant Ciprofloxacin-Susceptible Enterobacter cloacae Isolates (2008) (51)
- Clinical implications of stenotrophomonas maltophilia resistant to trimethoprim-sulfamethoxazole: a study of 69 patients at 2 university hospitals. (2000) (50)
- Revitalizing the antibiotic pipeline: Stimulating innovation while driving sustainable use and global access (2018) (49)
- Empiric Therapy With Carbapenem-Sparing Regimens for Bloodstream Infections due to Extended-Spectrum &bgr;-Lactamase–Producing Enterobacteriaceae: Results From the INCREMENT Cohort (2017) (49)
- Plasmid-encoded OXA-48 carbapenemase in Escherichia coli from Israel. (2011) (48)
- The impact of antibiotic use on transmission of resistant bacteria in hospitals: Insights from an agent-based model (2018) (47)
- Infection of a Ventriculoatrial Shunt with Phenotypically Variable Staphylococcus epidermidis Masquerading as Polymicrobial Bacteremia Due to Various Coagulase-Negative Staphylococci and Kocuria varians (2003) (47)
- Clinical Significance of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia (2003) (47)
- Dissemination of the CTX-M-25 family beta-lactamases among Klebsiella pneumoniae, Escherichia coli and Enterobacter cloacae and identification of the novel enzyme CTX-M-41 in Proteus mirabilis in Israel. (2008) (47)
- Efficacy of Ertapenem for Treatment of Bloodstream Infections Caused by Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae (2012) (47)
- Ertapenem for the treatment of bloodstream infections due to ESBL-producing Enterobacteriaceae: a multinational pre-registered cohort study. (2016) (45)
- Unique genes identified in the epidemic extremely drug-resistant KPC-producing Klebsiella pneumoniae sequence type 258. (2013) (45)
- Rectal Swabs Are Suitable for Quantifying the Carriage Load of KPC-Producing Carbapenem-Resistant Enterobacteriaceae (2013) (44)
- Regression of Kaposi's sarcoma after intravenous immunoglobulin treatment for polymyositis (1994) (44)
- Antimicrobial susceptibility of intra-abdominal Gram-negative bacilli from Europe: SMART Europe 2008 (2011) (43)
- Comparative Population Analysis of Klebsiella pneumoniae Strains with Extended-Spectrum β-Lactamases Colonizing Patients in Rehabilitation Centers in Four Countries (2013) (43)
- Detection and characterization of carbapenemase-producing Enterobacteriaceae in wounded Syrian patients admitted to hospitals in northern Israel (2015) (43)
- Carriage of extended-spectrum beta-lactamase-producing Enterobacteriaceae and the risk of surgical site infection after colorectal surgery: a prospective cohort study. (2018) (42)
- The effects of group 1 versus group 2 carbapenems on imipenem-resistant Pseudomonas aeruginosa: an ecological study. (2011) (42)
- A National Intervention to Prevent the Spread of Carbapenem-Resistant Enterobacteriaceae in Israeli Post-Acute Care Hospitals (2014) (42)
- The Magnitude of the Association between Fluoroquinolone Use and Quinolone-Resistant Escherichia coli and Klebsiella pneumoniae May Be Lower than Previously Reported (2004) (42)
- Risk Factors for Treatment Failure and Mortality Among Hospitalized Patients With Complicated Urinary Tract Infection: A Multicenter Retrospective Cohort Study (RESCUING Study Group) (2018) (41)
- Multicentre open-label randomised controlled trial to compare colistin alone with colistin plus meropenem for the treatment of severe infections caused by carbapenem-resistant Gram-negative infections (AIDA): a study protocol (2016) (41)
- Comparison of Predictors and Mortality Between Bloodstream Infections Caused by ESBL-Producing Escherichia coli and ESBL-Producing Klebsiella pneumoniae (2018) (41)
- Parental Staphylococcus aureus Carriage is Associated With Staphylococcal Carriage in Young Children (2009) (40)
- Strategies for managing today's infections. (2008) (39)
- Report of cases of and taxonomic considerations for large-colony-forming Lancefield group C streptococcal bacteremia (1995) (39)
- Geographical Variability in the Likelihood of Bloodstream Infections Due to Gram-Negative Bacteria: Correlation with Proximity to the Equator and Health Care Expenditure (2014) (39)
- First national surveillance of susceptibility of extended-spectrum beta-lactamase-producing Escherichia coli and Klebsiella spp. to antimicrobials in Israel. (2007) (38)
- Epidemiological and Microbiological Characteristics of an Outbreak Caused by OXA-48-Producing Enterobacteriaceae in a Neonatal Intensive Care Unit in Jerusalem, Israel (2013) (38)
- Laboratory evaluation of the CHROMagar KPC medium for identification of carbapenem-nonsusceptible Enterobacteriaceae. (2011) (38)
- Survey of metallo-β-lactamase-producing Enterobacteriaceae colonizing patients in European ICUs and rehabilitation units, 2008-11. (2015) (38)
- Clonal transmission of a rare methicillin-resistant Staphylococcus aureus genotype between horses and staff at a veterinary teaching hospital. (2013) (37)
- Fluoroquinolones Protective against Cephalosporin Resistance in Gram-negative Nosocomial Pathogens (2004) (37)
- Comparison of treatment with imipenem vs. ceftazidime as a predisposing factor for nosocomial acquisition of Stenotrophomonas maltophilia: a historical cohort study. (1997) (37)
- Carbapenem-Resistant KPC-2-Producing Escherichia coli in a Tel Aviv Medical Center, 2005 to 2008 (2010) (37)
- Pseudomonas aeruginosa bacteremia upon hospital admission: risk factors for mortality and influence of inadequate empirical antimicrobial therapy. (2011) (36)
- Detection of aac(6')-Ib-cr in KPC-producing Klebsiella pneumoniae isolates from Tel Aviv, Israel. (2009) (36)
- Carbapenem-resistant Klebsiella pneumoniae endocarditis in a young adult. Successful treatment with gentamicin and colistin. (2009) (36)
- A Swordless Knight: Epidemiology and Molecular Characteristics of the bla KPC-Negative Sequence Type 258 Klebsiella pneumoniae Clone (2012) (36)
- Antibodies raised against N'-terminal Pseudomonas aeruginosa flagellin prevent mortality in lethal murine models of infection. (2005) (35)
- Risk factors for colonization with extended-spectrum beta-lactamase-producing enterobacteriaceae on admission to rehabilitation centres. (2014) (35)
- Should third-generation cephalosporins be avoided against AmpC-inducible Enterobacteriaceae? (2004) (35)
- KPC-Like Carbapenemase-Producing Enterobacteriaceae Colonizing Patients in Europe and Israel (2015) (34)
- Development and validation of a multiplex PCR assay for identification of the epidemic ST-258/512 KPC-producing Klebsiella pneumoniae clone. (2014) (34)
- The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel (2013) (33)
- Efficacy of dalbavancin in the treatment of MRSA rat sternal osteomyelitis with mediastinitis. (2016) (32)
- Ceftazidime-Avibactam for the Treatment of Serious Gram-Negative Infections with Limited Treatment Options: A Systematic Literature Review (2021) (32)
- Predictors of outcome in patients with severe sepsis or septic shock due to extended-spectrum β-lactamase-producing Enterobacteriaceae. (2018) (32)
- Carriage of methicillin-resistant Staphylococcus aureus on admission to European rehabilitation centres--a prospective study. (2012) (32)
- Mix and match of KPC-2 encoding plasmids in Enterobacteriaceae-comparative genomics. (2014) (32)
- Antibiotic prophylaxis and the risk of Clostridium difficile-associated diarrhoea. (2001) (32)
- Incidence of and Preoperative Risk Factors for Staphylococcus aureus Bacteremia and Chest Wound Infection After Cardiac Surgery (2009) (32)
- Evaluation of carriage and environmental contamination by carbapenem-resistant Acinetobacter baumannii. (2016) (31)
- A clinical data repository enhances hospital infection control (1997) (31)
- Enterococcal bacteraemia: Epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance (2006) (31)
- Clinical Implications of Varying Degrees of Vancomycin Susceptilibity in Methicillin-Resistant Staphylococcus aureus Bacteremia (2003) (31)
- Colistin plus meropenem for carbapenem-resistant gram-negative infections: in vitro synergism is not associated with better clinical outcomes. (2020) (31)
- Serious hepatitis B vaccine adverse reactions, are they immune-mediated? (1993) (31)
- Prevalence and genetic relatedness of community-acquired methicillin-resistant Staphylococcus aureus in Israel (2006) (31)
- Development and validation of the INCREMENT-ESBL predictive score for mortality in patients with bloodstream infections due to extended-spectrum-&bgr;-lactamase-producing Enterobacteriaceae (2017) (30)
- Novel Rat Model of Methicillin-Resistant Staphylococcus aureus–Infected Silicone Breast Implants: A Study of Biofilm Pathogenesis (2013) (30)
- Microbiological diagnostics of bloodstream infections in Europe-an ESGBIES survey. (2019) (30)
- Stool Colonization of Healthcare Workers With Selected Resistant Bacteria (1998) (30)
- Risk Factors for Carbapenemase-Producing Carbapenem-Resistant Enterobacteriaceae (CP-CRE) Acquisition Among Contacts of Newly Diagnosed CP-CRE Patients (2016) (30)
- Dissemination of the blaKPC gene by clonal spread and horizontal gene transfer: comparative study of incidence and molecular mechanisms. (2016) (29)
- A multinational study of colonization with extended spectrum β-lactamase-producing Enterobacteriaceae in healthcare personnel and family members of carrier patients hospitalized in rehabilitation centres. (2014) (29)
- Therapy with anti-flagellin A monoclonal antibody limits Pseudomonas aeruginosa invasiveness in a mouse burn wound sepsis model. (2009) (29)
- The ERACE-PA Global Surveillance Program: Ceftolozane/tazobactam and Ceftazidime/avibactam in vitro Activity against a Global Collection of Carbapenem-resistant Pseudomonas aeruginosa (2021) (28)
- Control Group Selection Is an Important but Neglected Issue in Studies of Antibiotic Resistance (2000) (28)
- Effect of Resistance Mechanisms on the Inoculum Effect of Carbapenem in Klebsiella pneumoniae Isolates with Borderline Carbapenem Resistance (2015) (28)
- The Association Between Empirical Antibiotic Treatment and Mortality in Severe Infections Caused by Carbapenem-resistant Gram-negative Bacteria: A Prospective Study (2018) (28)
- Outbreak of adenovirus type 55 infection in Israel. (2016) (28)
- Antimicrobial resistance and patient outcomes: the hazards of adjustment (2006) (27)
- Spread of NDM-2-producing Acinetobacter baumannii in the Middle East. (2013) (26)
- Comparative Study of a Novel Biochemical Assay, the Rapidec Carba NP Test, for Detecting Carbapenemase-Producing Enterobacteriaceae (2015) (25)
- Clinical Isolation and Resistance Patterns of and Superinfection with 10 Nosocomial Pathogens after Treatment with Ceftriaxone versus Ampicillin-Sulbactam (2001) (25)
- Typhoid fever in Ethiopian immigrants to Israel and native-born Israelis: a comparative study. (1993) (25)
- Clostridium difficile fecal toxin level is associated with disease severity and prognosis (2017) (24)
- Streptococcal group C bacteremia. Survey in Israel and analytic review. (1995) (24)
- Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1) (2019) (24)
- The effect of antimicrobial resistance on patient outcomes: importance of proper evaluation of appropriate therapy (2009) (23)
- Epidemiological analysis of imipenem-resistant Serratia marcescens in hospitalized patients. (1999) (22)
- Predictors of pandemic (H1N1) 2009 virus positivity and adverse outcomes among hospitalized patients with a compatible syndrome. (2010) (22)
- Combining VITEK® 2 with colistin agar dilution screening assist timely reporting of colistin susceptibility. (2019) (22)
- The Establishment of a Pseudomonas aeruginosa-Infected Burn-Wound Sepsis Model and the Effect of Imipenem Treatment (2006) (22)
- Fighting bacterial resistance at the root: need for adapted EMEA guidelines. (2011) (22)
- Israeli National Policy for Carbapenem-Resistant Enterobacteriaceae Screening, Carrier Isolation and Discontinuation of Isolation (2017) (22)
- Personalized Ertapenem Prophylaxis for Carriers of Extended-spectrum β-Lactamase-producing Enterobacteriaceae Undergoing Colorectal Surgery. (2020) (21)
- Phylogenetic lineages, clones and β-lactamases in an international collection of Klebsiella oxytoca isolates non-susceptible to expanded-spectrum cephalosporins. (2015) (21)
- Estimating the association between antibiotic exposure and colonisation with ESBL-producing Gram negative bacteria: a multicentre, prospective cohort study. (2019) (21)
- Emergence of VIM-producing Aeromonas caviae in Israeli hospitals. (2014) (20)
- Detection of the plasmid-mediated KPC-2 carbapenem-hydrolysing enzyme in three unusual species of the Enterobacteriaceae family in Israel. (2013) (20)
- Fourier Transform Infrared Spectroscopy Is a New Option for Outbreak Investigation: a Retrospective Analysis of an Extended-Spectrum-Beta-Lactamase-Producing Klebsiella pneumoniae Outbreak in a Neonatal Intensive Care Unit (2020) (20)
- Success of a National Intervention in Controlling Carbapenem-resistant Enterobacteriaceae in Israel’s Long-term Care Facilities (2018) (20)
- Hepatitis B vaccine side-effect (1993) (20)
- Staphylococcus aureus mediastinitis and sternal osteomyelitis following median sternotomy in a rat model. (2008) (19)
- Unexpected hospital-acquired bacteraemia in patients at low risk of bloodstream infection: the role of a heparin drip. (2005) (19)
- Prevalence, Risk Factors, and Transmission Dynamics of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: a National Survey of Cattle Farms in Israel in 2013 (2015) (19)
- Prevalence and risk factors for colonization with methicillin resistant Staphylococcus aureus and other Staphylococci species in hospitalized and farm horses in Israel. (2015) (19)
- Extremely low prevalence of asymptomatic COVID-19 among healthcare workers caring for COVID-19 patients in Israeli hospitals: a cross-sectional study (2020) (18)
- Clinical Significance and Antibiotic Resistance Patterns of Leminorella spp., an Emerging Nosocomial Pathogen (2000) (18)
- The pivotal role of long-term care facilities in the epidemiology of Acinetobacter baumannii: another brick in the wall. (2010) (18)
- Molecular Epidemiology of Methicillin-Resistant Staphylococcus aureus in Israel: Dissemination of Global Clones and Unique Features (2011) (18)
- Extended-spectrum β-lactamase-producing Shigella strains in Israel, 2000–2004 (2007) (18)
- Utility of the VITEK 2 Advanced Expert System for Identification of Extended-Spectrum β-Lactamase Production in Enterobacter spp (2006) (17)
- The economic effect of oral linezolid versus intravenous vancomycin in the outpatient setting: the payer perspective. (2007) (17)
- SCCmec and spa types of methicillin-resistant Staphylococcus aureus strains in Israel. Detection of SCCmec type V (2008) (17)
- Metagenomic Characterization of Gut Microbiota of Carriers of Extended-Spectrum Beta-Lactamase or Carbapenemase-Producing Enterobacteriaceae Following Treatment with Oral Antibiotics and Fecal Microbiota Transplantation: Results from a Multicenter Randomized Trial (2020) (17)
- Studies of Bloodstream Infection Outcomes: Reading Between the Lines (2003) (17)
- High prevalence of methicillin-resistant Staphylococcus aureus among residents and staff of long-term care facilities, involving joint and parallel evolution. (2011) (16)
- Genotypic and phenotypic analysis of Clostridium difficile correlated with previous antibiotic exposure. (2006) (16)
- A multicenter study of the clonal structure and resistance mechanism of KPC-producing Escherichia coli isolates in Israel. (2015) (16)
- Congenital tuberculosis and management of exposure in neonatal and pediatric intensive care units. (2014) (16)
- Cost-effectiveness evaluation of ertapenem versus piperacillin/tazobactam in the treatment of complicated intraabdominal infections accounting for antibiotic resistance. (2009) (15)
- Methicillin-Resistant Staphylococcus aureus spa Type t002 Outbreak in Horses and Staff at a Veterinary Teaching Hospital after Its Presumed Introduction by a Veterinarian (2015) (15)
- High rates of intestinal colonisation with fluoroquinolone-resistant ESBL-harbouring Enterobacteriaceae in hospitalised patients with antibiotic-associated diarrhoea (2014) (15)
- Quantifying antibiotic impact on within-patient dynamics of extended-spectrum beta-lactamase resistance (2020) (15)
- Failure of Quality Control Measures To Prevent Reporting of False Resistance to Imipenem, Resulting in a Pseudo-Outbreak of Imipenem-Resistant Pseudomonas aeruginosa (1998) (15)
- Incidence and Risk Factors for Community and Hospital Acquisition of Clostridium difficile Infection in the Tel Aviv Sourasky Medical Center (2017) (15)
- Is prolonged antibiotic prophylaxis after major surgery associated with an increased risk of nosocomial bloodstream infection? (2000) (14)
- The Impact of a Carbapenem-Resistant Enterobacteriaceae Outbreak on Facilitating Development of a National Infrastructure for Infection Control in Israel (2017) (13)
- Evolution and dissemination of the Klebsiella pneumoniae clonal group 258 throughout Israeli post-acute care hospitals, 2008–13 (2017) (13)
- Environmental contamination by carbapenem-resistant Acinetobacter baumannii: The effects of room type and cleaning methods (2019) (13)
- Citrobacter telavivum sp. nov. with chromosomal mcr-9 from hospitalized patients (2020) (13)
- Dissemination of the Klebsiella pneumoniae Carbapenemase in the Health Care Settings: Tracking the Trails of an Elusive Offender (2011) (13)
- Culture-based detection of methicillin-resistant Staphylococcus aureus by a network of European laboratories: an external quality assessment study (2012) (12)
- Rapid identification of capsulated Acinetobacter baumannii using a density-dependent gradient test (2020) (12)
- EpideMiology and control measures of outBreaks due to Antibiotic-Resistant orGanisms in EurOpe (EMBARGO): a systematic review protocol (2017) (12)
- Lessons From an Outbreak of Varicella Infection in Pediatric Hemato-oncology Patients (2018) (12)
- Efficacy of Antibodies against the N-Terminal of Pseudomonas aeruginosa Flagellin for Treating Infections in a Murine Burn Wound Model (2006) (12)
- Characteristics of microorganisms cultured from infected wounds post-hysterectomy. (2008) (12)
- Evaluation of an Accelerated Protocol for Detection of Extended-Spectrum β-Lactamase-Producing Gram-Negative Bacilli from Positive Blood Cultures (2005) (12)
- Prevalence and risk factors for carriage of extended-spectrum β-lactamase-producing Enterobacteriaceae among patients prior to bowel surgery. (2016) (11)
- Population pharmacokinetics of colistin and the relation to survival in critically ill patients infected with colistin susceptible and carbapenem-resistant bacteria. (2020) (11)
- Trends and changes in Clostridium difficile diagnostic policies and their impact on the proportion of positive samples: a national survey. (2014) (11)
- Detecting carbapenem-resistant Acinetobacter baumannii (CRAB) carriage: Which body site should be cultured? (2020) (11)
- Antibiotic therapy in the demented elderly population: redefining the ethical dilemma. (2008) (11)
- Accounting for the Development of Antibacterial Resistance in the Cost Effectiveness of Ertapenem versus Piperacillin/Tazobactam in the Treatment of Diabetic Foot Infections in the UK (2012) (10)
- Investigation of Outbreaks of Extended-Spectrum Beta-Lactamase-Producing Klebsiella Pneumoniae in Three Neonatal Intensive Care Units Using Whole Genome Sequencing (2020) (10)
- Cost Analysis of an Intervention to Prevent Methicillin-Resistant Staphylococcus Aureus (MRSA) Transmission (2015) (10)
- Trends in antimicrobial resistance in Israel, 2014–2017 (2019) (10)
- Characterization of Two New CTX-M-25-Group Extended-Spectrum β-Lactamase Variants Identified in Escherichia coli Isolates from Israel (2012) (10)
- Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel (2018) (10)
- Ceftobiprole medocaril is an effective treatment against methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a rat model (2014) (10)
- Outbreak of multidrug-resistant Pseudomonas aeruginosa infection following urodynamic studies traced to contaminated transducer. (2013) (9)
- Colistin Resistance Development Following Colistin-Meropenem Combination Therapy vs. Colistin Monotherapy in Patients with Infections Caused by Carbapenem-Resistant Organisms. (2019) (9)
- Droplet aerosol dissemination of carbapenem-resistant Acinetobacter baumannii surrounding ventilated patients (2019) (9)
- Characteristics of SCCmec IV and V Methicillin-Resistant Staphylococcus aureus (MRSA) in Israel. (2015) (9)
- External validation of the INCREMENT-CPE mortality score in a carbapenem-resistant Klebsiella pneumoniae bacteremia cohort: The prognostic significance of colistin resistance. (2019) (9)
- A binational cohort study of intestinal colonization with extended-spectrum β-lactamase-producing Proteus mirabilis in patients admitted to rehabilitation centres. (2013) (9)
- Late‐onset bloodstream infections in preterm infants: A 2‐year survey (2012) (9)
- Utility of clinical symptoms versus laboratory tests for evaluation of acute gastroenteritis (1996) (9)
- Likelihood of Inadequate Treatment A Novel Approach to Evaluating Drug-Resistance Patterns (2009) (9)
- Protocol for the Accelerated Detection of Extended-Spectrum β-Lactamase-Producing Escherichia coli and Klebsiella pneumoniae Strains from Blood Cultures (2004) (9)
- Geographical variation in therapy for bloodstream infections due to multidrug-resistant Enterobacteriaceae: a post-hoc analysis of the INCREMENT study. (2017) (8)
- Prevalence of anti-hepatitis B surface antibodies among children and adolescents vaccinated in infancy and effect of booster dose administered within a pilot study (2017) (8)
- Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2) (2019) (8)
- The effect of prophylaxis with ertapenem versus cefuroxime/metronidazole on intestinal carriage of carbapenem-resistant or third-generation cephalosporin-resistant Enterobacterales after colorectal surgery. (2021) (8)
- Molecular types and antimicrobial susceptibility patterns of Clostridium difficile isolates in different epidemiological settings in a tertiary care center in Israel. (2016) (8)
- Effect of a national policy of universal masking and uniform criteria for severe acute respiratory coronavirus virus 2 (SARS-CoV-2) exposure on hospital staff infection and quarantine (2021) (8)
- Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3) (2019) (7)
- Zero or more: methodological challenges of counting and estimating deaths related to antibiotic-resistant infections. (2019) (7)
- Extended-spectrum beta-lactamase-producing Shigella strains in Israel, 2000-2004. (2007) (7)
- Sequence Type 258 United States : Clonal Expansion of Isolates in the Klebsiella pneumoniae Molecular Epidemiology of KPC-Producing (2009) (7)
- Antimicrobial use trends, Israel, 2012 to 2017 (2019) (7)
- Ceftazidime-avibactam in ceftazidime-resistant infections. (2016) (7)
- Laboratory evaluation of different agar media for isolation of carbapenem-resistant Acinetobacter spp. (2014) (7)
- Elderly bedridden patients with dementia use over one quarter of resources in internal medicine wards in an Israeli hospital (2020) (6)
- Time to Detection with BacT/Alert FA Plus Compared to BacT/Alert FA Blood Culture Media (2016) (6)
- A silent outbreak of vancomycin-resistant Enterococcus faecium in a neonatal intensive care unit (2020) (6)
- Surgical antibiotic prophylaxis in patients colonized with multidrug-resistant Gram-negative bacteria: practical and conceptual aspects. (2021) (6)
- A mathematical model of Clostridium difficile transmission in medical wards and a cost-effectiveness analysis comparing different strategies for laboratory diagnosis and patient isolation (2017) (6)
- spectrum β-lactamase producing Enterobacteriaceae (2012) (6)
- Ergot Induced Myocardial Ischaemia in a Patient without Vasospastic Disorder (1994) (5)
- Laboratory evaluation of the ESwab transport system for the recovery of carbapenem-resistant Acinetobacter baumannii (2012) (5)
- Immigration of Ethiopians with typhoid fever to Israel: apparent lack of influence on the local population. (1994) (5)
- Clinical and Microbiological Outcomes of Ceftazidime-Avibactam Treatment in Adults with Gram-Negative Bacteremia: A Subset Analysis from the Phase 3 Clinical Trial Program (2021) (5)
- Performance of Rapid Polymyxin™ NP and Rapid Polymyxin™ Acinetobacter for the detection of polymyxin resistance in carbapenem-resistant Acinetobacter baumannii and Enterobacterales. (2020) (4)
- A nationwide population-based study of Escherichia coli bloodstream infections: incidence, antimicrobial resistance and mortality. (2021) (4)
- Prevalence of extended-spectrum betalactamase producing–Enterobacteriaceae (ESBL-E) carriage on admission at Geneva University Hospitals (HUG) (2015) (4)
- SCCmec and spa types of methicillin-resistant Staphylococcus aureus strains in Israel. Detection of SCCmec type V (2008) (4)
- Elevated MICs of Susceptible Antipseudomonal Cephalosporins in Non-Carbapenemase-Producing, Carbapenem-Resistant Pseudomonas aeruginosa: Implications for Dose Optimization (2021) (4)
- In vivo Fitness of Acinetobacter baumannii Strains in Murine Infection Is Associated with International Lineage II-rep-2 and International Lineage III Clones Showing High Case Fatality Rates in Human Infections (2020) (4)
- Colistin Monotherapy versus Combination Therapy for Carbapenem-Resistant Organisms (2022) (4)
- The association between implementation of second-tier prevention practices and CLABSI incidence: A national survey (2019) (4)
- Antibiotic exposure and the risk of hospital-acquired diarrhoea and Clostridioides difficile infection: a cohort study. (2021) (4)
- Sero-Prevalence and Sero-Incidence of Antibodies to SARS-CoV-2 in Health Care Workers in Israel, Prior to Mass COVID-19 Vaccination (2021) (4)
- Stool colonization of healthcare workers with selected resistant bacteria. (1998) (4)
- Safety, efficacy, and pharmacokinetics of gremubamab (MEDI3902), an anti-Pseudomonas aeruginosa bispecific human monoclonal antibody, in P. aeruginosa-colonised, mechanically ventilated intensive care unit patients: a randomised controlled trial (2022) (4)
- Does Acinetobacter baumannii Serve as a Source for blaNDM Dissemination into Enterobacteriaceae in Hospitalized Patients? (2018) (4)
- Excluded versus included patients in a randomized controlled trial of infections caused by carbapenem-resistant Gram-negative bacteria: relevance to external validity (2021) (4)
- Correction for Adler et al., Prevalence, Risk Factors, and Transmission Dynamics of Extended-Spectrum-β-Lactamase-Producing Enterobacteriaceae: a National Survey of Cattle Farms in Israel in 2013 (2016) (4)
- Preventing tuberculosis transmission at a maternity hospital by targeted screening radiography of migrants. (2015) (4)
- Controlling Hospital-Acquired Infection due to Carbapenem-Resistant Enterobacteriaceae (CRE) (2012) (3)
- Draft Genome Sequence of an Extremely Drug-Resistant KPC-Producing Klebsiella pneumoniae ST258 Epidemic Strain (2012) (3)
- Re: 'colistin plus meropenem for carbapenem-resistant gram-negative infections: in vitro synergism is not associated with better clinical outcomes' - Author's reply. (2020) (3)
- Increased Capsule Thickness and Hypermotility Are Traits of Carbapenem-Resistant Acinetobacter baumannii ST3 Strains Causing Fulminant Infection (2021) (3)
- Blood Culture Sampling Practices among Internal Medicine Inpatients (2017) (3)
- Use of Insurance Claims Data to Assess Outpatient Antimicrobial Therapy for Gram‐Positive Infections (2002) (3)
- Comparative population analysis of Klebsiella pneumoniae with extended (2013) (3)
- Effect of Various Antibacterial Preparations on the Pathogenic Oral Flora in Elderly Patients Fed via Nasogastric Tube (2005) (3)
- OXA-900, a Novel OXA Sub-Family Carbapenemase Identified in Citrobacter freundii, Evades Detection by Commercial Molecular Diagnostics Tests (2021) (3)
- Hospital-Onset Bloodstream Infections Caused by Eight Sentinel Bacteria: A Nationwide Study in Israel, 2018–2019 (2022) (3)
- Multiplex lateral flow immunochromatographic assay is an effective method to detect carbapenemases without risk of OXA-48-like cross reactivity (2021) (3)
- Draft Genome Sequences of Two Multidrug-Resistant Extended-Spectrum-β-Lactamase-Producing Klebsiella pneumoniae Strains Causing Bloodstream Infections (2016) (3)
- Control interventions for preventing spread of vancomycin-resistant enterococci (VRE) in hospitals (2008) (2)
- Multicenter, Prospective Validation of a Phenotypic Algorithm to Guide Carbapenemase Testing in Carbapenem-Resistant Pseudomonas aeruginosa Using the ERACE-PA Global Surveillance Program (2021) (2)
- One-year mortality and years of potential life lost following bloodstream infection among adults: A nation-wide population based study (2022) (2)
- Likelihood of persistent carriage of carbapenem-resistant Acinetobacter baumannii on readmission in previously identified carriers (2019) (2)
- Surgical Treatment for Crohn's Disease of the Fourth Part of the Duodenum (1990) (2)
- Paradoxic, glycerol-trinitrate induced hypertension. (1994) (2)
- Combination therapy for bloodstream infections with carbapenemase-producing Enterobacteriaceae - Authors' reply. (2017) (2)
- Evolution of high-level daptomycin resistance in Enterococcus faecium during daptomycin therapy is associated with limited mutations in the bacterial genome (2013) (2)
- Clostridium difficile‐associated disease and Helicobacter pylori seroprevalence: A case‐control study (2019) (2)
- Gentamicin- and Ciprofloxacin-Resistant Enterobacteriaceae in Cattle Farms in Israel: Risk Factors for Carriage and the Effect of Microbiological Methodology on the Measured Prevalence. (2017) (2)
- Effect of temperature on Escherichia coli bloodstream infection in a nationwide population-based study of incidence and resistance (2022) (2)
- Analysis of four carbapenem-resistant Acinetobacter baumannii outbreaks using Fourier-transform infrared spectroscopy. (2022) (2)
- National Policy for CRE Clearance and Discontinuation of Contact Precautions for CRE Carriers in Post-Acute Care Hospitals in Israel: Impact on Isolation-Days and New Acquisitions. (2020) (2)
- The emergence and dissemination of CTX-M-producing Escherichia coli sequence type 131 causing community-onset bacteremia in Israel (2012) (2)
- Prospective assessment of microsatellite instability in gastrointestinal neoplasia in Ashkenazi and non-Ashkenazi Jews. (2003) (1)
- Failure of Broth-Based Tests to Detect Methicillin-Resistant Staphylococcus aureus in a Clinical Specimen (2004) (1)
- Prevalence of extended-spectrum betalactamase producing–Enterobacteriaceae (ESBL-E) carriage on admission at Geneva University Hospitals (HUG) (2015) (1)
- Hospital-acquired bacterial infections in coronavirus disease 2019 (COVID-19) patients in Israel. (2022) (1)
- 638. The Impact of in vitro Synergy Between Colistin and Meropenem on Clinical Outcomes in Invasive Carbapenem-resistant Gram-negative Infections: A Report from the OVERCOME Trial (2021) (1)
- Dissemination of the bla KPC gene by clonal spread and horizontal gene transfer: comparative study of incidence and molecular mechanisms (2016) (1)
- 363Persistence of the Klebsiella pneumoniae Sequence Type 258 as the Predominant Clone of Carbapenemase-Producing Enterobacteriaceae in Post-Acute Care Facilities in Israel, 2008-2013 (2014) (1)
- The Israeli national policy for discontinuation of isolation of carbapenem-resistant enterobacterales carriers by carbapenemase type: a retrospective cohort study. (2021) (1)
- An analysis of 7 years of blood cultures: epidemiology, microbiology and mortality (2017) (1)
- Emergence of antibiotic resistant Pseudomonas aeruginosa (PA): the association with various antipseudomonal agents (1997) (1)
- Pseudomonas resistance in hospital setting; why pseudomonas sparing is an important AMS strategy (2014) (1)
- 1477. A Randomized Phase 2 Study of Cefepime Combined with the Novel Extended Spectrum β-Lactamase Inhibitor Enmetazobactam in Hospitalized Adults with Complicated Urinary Tract Infections (cUTI) Including Acute Pyelonephritis (AP) (2019) (1)
- Differential Effects of Levofloxacin and Ciprofloxacin on the Risk for Isolation of Quinolone-Resistant Pseudomonas aeruginosa (2006) (1)
- Utilising sigmoid models to predict the spread of antimicrobial resistance at the country level (2020) (1)
- ESBL-production is associated with an increase of cell invasion and fimbrial adhesins' expression in Klebsiella pneumoniae (2008) (1)
- Enhanced Humoral Immune Responses against Toxin A and B of Clostridium difficile is Associated with a Milder Disease Manifestation (2020) (1)
- SCC mec and spa types of methicillin-resistant Staphylococcus aureus strains in Israel . Detection of SCC mec type V (2007) (1)
- Colistin Dependency among Colistin-Heteroresistant Acinetobacter baumannii Isolates (2021) (1)
- Reply to Zavascki (2004) (1)
- Broadening the infection prevention and control network globally; 2017 Geneva IPC-think tank (part 3) (2019) (1)
- Spontaneous gastric perforation. (2006) (1)
- 630. Emergence of Colistin Resistance in the OVERCOME Trial: Impact of Combination Therapy with Meropenem (2021) (0)
- MINIREVIEW Effects of Antibiotics on Nosocomial Epidemiology of Vancomycin-Resistant Enterococci (2002) (0)
- Evaluation of PCR-Based Testing for Surveillance of KPC-Producing Carbapenem- 1 (2009) (0)
- Large-scale WGS of carbapenem-resistant Acinetobacter baumannii isolates reveals patterns of dissemination of ST clades associated with antibiotic resistance. (2022) (0)
- Carriage of vancomycin-resistant Enterococcus faecium in infants following an outbreak in the neonatal intensive care unit: time to clearance of carriage and use of molecular methods to detect colonization (2022) (0)
- pneumoniae ST258 Epidemic Strain Drug-Resistant KPC-Producing Klebsiella Draft Genome Sequence of an Extremely (2012) (0)
- Nosocomial Superinfections with Gram-Negative Pathogens and Quinolone Resistance after Treatment with Ciprofloxacin vs Ofloxacin (1999) (0)
- Mycobacterium intracellulare subsp. chimaera from Cardio Surgery Heating-Cooling Units and from Clinical Samples in Israel Are Genetically Unrelated (2021) (0)
- Prevalence and risk factors for methicillin-resistant Staphylococcus aureus (MRSA) carriage on admission to different hospital sectors in two European countries (2011) (0)
- Pandora’s box in the dental clinic (2021) (0)
- Reply to Cicalini et al. (2004) (0)
- Unraveling the Diversity of Co-Colonization by CPE (2022) (0)
- Laboratory evaluation of the ESwab transport system for the recovery of carbapenem-resistant Acinetobacter baumannii (2011) (0)
- Broadened definition for hospital-acquired infective endocarditis [2] (multiple letters) (2004) (0)
- Epidemiological investigations in a digital era: methods and tools to identify infectious disease outbreaks (2015) (0)
- Comparing Efficacy of Common Pocket Irrigation Protocols in an Infected Breast Implant Model (2020) (0)
- Detection and characterization of carbapenemase-producing Enterobacteriaceae in wounded Syrian patients admitted to hospitals in northern Israel (2015) (0)
- Analysis of Blood Culture Collection and Laboratory Processing Practices in Israel (2022) (0)
- A multi-institutional outbreak of New Delhi metallo-β-lactamase–producing Escherichia coli with subsequent acquisition of the Klebsiella pneumoniae carbapenemase gene (2020) (0)
- Ceftazidime-Avibactam Can Treat UTIs Caused by Multidrug-Resistant Enterobacteriaceae (2015) (0)
- Carbapenem-resistant Acinetobacter baumannii load in patients and their environment: the importance of detecting carriers. (2023) (0)
- P1400 Pharmaco-economic impact accounting for future resistance of ertapenam vs. piperacillin/tazobactam in the treatment of community-acquired complicated intra-abdominal infections in the Netherlands (2007) (0)
- Running title: KPC in carbapenem-resistant K. pneumoniae in Israel (2007) (0)
- Broadened definition for hospital-acquired infective endocarditis. Authors' reply (2004) (0)
- Compléments : Ceftazidime-avibactam in ceftazidime-resistant infections (2016) (0)
- Epidemiological investigations in a digital era: methods and tools to identify infectious disease outbreaks (2015) (0)
- Culture-based detection of methicillin-resistant Staphylococcus aureus by a network of European laboratories: an external quality assessment study (2011) (0)
- Evaluation of the MICRONAUT MIC-strip colistin assay for colistin susceptibility testing of carbapenem-resistant Acinetobacter baumannii and Enterobacterales. (2021) (0)
- Corrigendum to "Outbreak of adenovirus type 55 infection in Israel" [J. Clin. Virol. 78 (2016) 31-35]. (2016) (0)
- Mycobacterium chimaera from Cardio Surgery Heating-Cooling Units and from Clinical Samples in Israel are Genetically Unrelated (2021) (0)
- Colistin versus colistin plus meropenem for severe infections Authors' reply. (2018) (0)
- Carbapenems Synergy of Polymyxins and Vitro In Systematic Review and Meta-Analysis of (2014) (0)
- 2088. Association Between Implementation of Prevention Practices and CLABSI Incidence: A National Survey (2018) (0)
- Citrobacter telavivum sp. nov. with chromosomal mcr-9 from hospitalized patients (2020) (0)
- 217. A Phase 1 Study of the Safety, Tolerability, and Pharmacokinetics of Multiple Doses of the Lipopeptide QPX9003 in Healthy Adult Subjects (2022) (0)
- [Enteral feeding in the elderly--bad news and good news]. (1994) (0)
- Risk factors for recurrent Clostridium difficile infection in a tertiary hospital in Israel (2018) (0)
- A National Intervention to Reduce Undesirable Urinary Tract Events in Internal Medicine Wards (2020) (0)
- Trends in antimicrobial resistance in Israel, 2014–2017 (2019) (0)
- Clostridium difficile infection in medical wards – a mathematical model (2015) (0)
- P283: The challenge of preventing nosocomial exposure to tuberculosis (TB) related to migrants from high incidence countries (2013) (0)
- Reply to Apisarnthanarak and Apisarnthanarak. (2020) (0)
- Author response: Quantifying antibiotic impact on within-patient dynamics of extended-spectrum beta-lactamase resistance (2019) (0)
- Ceftobiprole medocaril is an effective treatment against methicillin-resistant Staphylococcus aureus (MRSA) mediastinitis in a rat model (2013) (0)
- Time to Detection with BacT/Alert FA Plus Compared to BacT/Alert FA Blood Culture Media (2016) (0)
- Laboratory evaluation of different agar media for isolation of carbapenem-resistant Acinetobacter spp. (2014) (0)
- P1399 Cost-effectiveness of ertapenem vs. piperacillin/tazobactam in the treatment of diabetic foot infections in the United Kingdom accounting for development of antibiotic resistance (2007) (0)
- Technology for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva IPC-Think Tank (Part 2) (2019) (0)
- 739. The High Burden of Bloodstream Infection in Adults: A Nation-Wide Population- Based Study (2022) (0)
- A Case of Leuconostoc Ventriculitis with Resistance to Carbapenem Antibiotics (2003) (0)
- The Impact of a National Intervention on Hospital-Acquired Bloodstream Infection Rates in Israeli Intensive Care Units (2017) (0)
- Targeted Screening for Multiple Drug-Resistant Gram-Negatives: Medical and Economic Implications (2008) (0)
- Oral Session Molecular detection of resistence: dream or reality? THE TALE OF TWO OUTBREAKS: MONO- VS. MULTI-SPECIES COLONIZATION BY KPC- PRODUCING ENTEROBACTERIACEAE (2014) (0)
- Reply to Wilson et al. (2019) (0)
- High rates of intestinal colonisation with fluoroquinolone-resistant ESBL-harbouring Enterobacteriaceae in hospitalised patients with antibiotic-associated diarrhoea (2014) (0)
- Targeted decolonization to prevent ICU infections. (2013) (0)
- P283: The challenge of preventing nosocomial exposure to tuberculosis (TB) related to migrants from high incidence countries (2013) (0)
- Healthcare-associated infection prevention and control practices in Israel: results of a national survey (2022) (0)
- combinations are risk factors for the isolation of extended-spectrum β-lactamase- 2 (2010) (0)
- [Antibiotic stewardship--state of the art]. (2014) (0)
- Shaked H, Carmeli Y, Schwartz D, Siegman-Igra Y. Enterococcal bacteremia: epidemiological, microbiological, clinical and prognostic characteristics, and the impact of high level gentamicin resistance (2006) (0)
- Phenotypic and Genomic Characterization of Nine String-Positive Carbapenem-Resistant Acinetobacter baumannii Isolates from Israel (2023) (0)
- A multinational study of colonization with ESBL-producing Enterobacteriaceae in healthcare personal and family members of carrier patients hospitalized in rehabilitation centers. (2014) (0)
- Antibiotic consumption in post-acute care and geriatric hospitals in Israel, 2014 (2015) (0)
- Multiplex lateral flow immunochromatographic assay is an effective method to detect carbapenemases without risk of OXA-48-like cross reactivity (2021) (0)
- The possibility of transmitting infections with vaginal ultrasound probes: why the guidelines must be met (2019) (0)
- Clostridium difficile infection in medical wards – a mathematical model (2015) (0)
- Bacteremia Upon Hospital Admission (UHA): Should Pseudomonas aeruginosa (PA) be Suspected? (2006) (0)
- A Gram-negative From Hell (2014) (0)
- Influential Publications in Healthcare Epidemiology and Infection Control from the Past Year (2017) (0)
- characteristics of scc mec iv and v m ethicillin-r esistant s taphylococcus aureus (mrsa) in i srael (2015) (0)
- Knowledge is Power: Using Epidemiology to Optimize Control Strategies for Carbapenem-Reistant Gram Negative Rods (2014) (0)
- Treatment with β-lactams and superinfection with Stenotrophomonas maltophilia: A historical cohort study could show us more [3] (multiple letters) (1998) (0)
- In vivo fitness of carbapenem-resistant Acinetobacter baumannii (CRAB) strains in murine infection is associated with treatment failure in human infections. (2021) (0)
- pneumoniae Clone -Negative Sequence Type 258 Klebsiella KPC bla Molecular Characteristics of the A Swordless Knight: Epidemiology and (2012) (0)
- Commentary Antimicrobial resistance and patient outcomes: the hazards of (2006) (0)
- Survey in Israel and Analytic Review (2016) (0)
- Laboratory and Clinical Evaluation of Screening Agar Plates for Detection of Carbapenem-Resistant Enterobacteriaceae from Surveillance Rectal Swabs (cid:1) (2011) (0)
- Antibiotic consumption in post-acute care and geriatric hospitals in Israel, 2014 (2015) (0)
- Implementation research for the prevention of antimicrobial resistance and healthcare-associated infections; 2017 Geneva infection prevention and control (IPC)-think tank (part 1) (2019) (0)
- Quantifying antibiotic impact on within-host dynamics of extended-spectrum beta-lactamase resistance in hospitalized patients (2019) (0)
- Pattern of Persons with Dengue, Northeastern Brazil (2011) (0)
- Antibacterial dermaseptin S4 derivatives (2001) (0)
- producing Enterobacteriaceae: a national survey of cattle farms in 2 (2015) (0)
- Clinical Impact of Antimicrobial Resistance in Hospitalized Patients: a Systematic Review (2019) (0)
This paper list is powered by the following services:
What Schools Are Affiliated With Yehuda Carmeli?
Yehuda Carmeli is affiliated with the following schools:
